Tramadol is stronger than codeine on a milligram-for-milligram basis. Using standard opioid conversion factors, 1 mg of tramadol equals 0.4 mg of morphine, while 1 mg of codeine equals only 0.15 mg of morphine. That makes tramadol roughly 2.5 times more potent per milligram. But raw potency doesn’t tell the whole story, because these two drugs work in fundamentally different ways and carry different risks.
How the Potency Numbers Compare
Doctors compare opioid strength by converting each drug to an equivalent dose of morphine, called oral morphine equivalents (OME). Codeine has a conversion factor of 0.15, meaning 100 mg of codeine provides about the same pain relief as 15 mg of oral morphine. Tramadol’s conversion factor is 0.4, so 100 mg of tramadol is equivalent to roughly 40 mg of morphine.
Clinical trial data backs this up. In a large meta-analysis of over 3,400 postoperative patients, codeine 60 mg alone performed poorly for dental pain, with results that weren’t statistically distinguishable from placebo. Tramadol at the same dose range showed clear, dose-dependent pain relief. For postsurgical pain, tramadol 100 mg provided meaningful relief for about 1 in 5 patients who took it (compared to placebo), while codeine 60 mg helped roughly 1 in 9. Tramadol 150 mg performed even better, helping about 1 in 2.4 patients.
Why They Work Differently in Your Body
Codeine is essentially a prodrug. It has very little painkilling ability on its own. Your liver must convert it into morphine using an enzyme called CYP2D6, and only about 5 to 10% of a codeine dose actually gets converted. The remaining 80% or more becomes inactive byproducts your body simply eliminates. This means codeine’s effectiveness depends almost entirely on how well your personal enzyme system handles that conversion.
Tramadol works through two separate pathways. Its main metabolite activates opioid receptors in the brain, similar to other opioid painkillers. But tramadol also blocks the reabsorption of serotonin and norepinephrine, two brain chemicals that help dampen pain signals through a completely separate system. This dual mechanism is why tramadol can provide broader pain relief than its opioid activity alone would suggest, and it’s also why tramadol carries some unique risks that codeine does not.
Your Genetics Change the Equation
Both codeine and tramadol rely on the same liver enzyme, CYP2D6, to produce their active pain-relieving forms. But people carry different versions of the gene for this enzyme, and the differences are dramatic.
Poor metabolizers lack working copies of CYP2D6. For these people, codeine provides almost no pain relief because very little morphine gets produced. Tramadol also becomes less effective, though its serotonin and norepinephrine effects still contribute some pain relief even without full opioid activation.
Ultra-rapid metabolizers sit at the other extreme. Their bodies convert codeine to morphine much faster and in larger amounts than expected, which can cause dangerous levels of sedation or breathing problems from a standard dose. The prevalence of ultra-rapid metabolizers varies widely by population. Some groups show rates as high as 18%, while others fall below 5%. This genetic variability is one reason codeine has fallen out of favor for certain patient groups, particularly children.
Side Effects and Safety Risks
Codeine’s side effect profile is typical of opioids: constipation, drowsiness, nausea, and at higher doses, slowed breathing. Because it converts to morphine, the risks scale with how efficiently your body makes that conversion.
Tramadol shares those opioid side effects but adds risks tied to its effects on serotonin and norepinephrine. The most notable is serotonin syndrome, a potentially dangerous condition involving agitation, rapid heart rate, muscle twitching, and confusion. This risk climbs significantly if you take tramadol alongside common antidepressants, including SSRIs like sertraline, citalopram, fluoxetine, and paroxetine, or SNRIs like venlafaxine. Case reports of serotonin syndrome from these combinations are well documented. Codeine does not carry this risk.
Tramadol also carries a seizure warning. A large nested case-control study found that when using a specific definition of seizures, tramadol was associated with a 41% higher risk compared to codeine. Seizures have been reported at standard therapeutic doses, not just in overdose situations. This risk was flagged within a year of tramadol’s U.S. approval in 1995 and remains on the drug’s label.
How They’re Scheduled
Despite being the weaker drug, codeine-containing products are classified more strictly by the DEA. Combination products with less than 90 mg of codeine per dose (like Tylenol with codeine) are Schedule III, while low-concentration cough preparations are Schedule V. Tramadol is Schedule IV, reflecting its lower assessed potential for abuse and dependence. This scheduling difference means tramadol prescriptions generally face fewer restrictions, though both drugs can cause physical dependence with regular use.
Typical Dosing Ranges
Tramadol immediate-release tablets typically start at 25 mg per day, with gradual increases up to a maximum of 400 mg daily. Extended-release formulations start at 100 mg once daily, capping at 300 mg. Codeine for pain is commonly dosed at 15 to 60 mg every four to six hours, often in combination with acetaminophen.
Because tramadol is more potent per milligram, the prescribed doses of each drug aren’t directly interchangeable. Switching between them requires recalculating the equivalent dose using morphine equivalents, not simply matching the number of milligrams.
Which One Works Better in Practice
For acute pain like post-surgical or dental pain, the clinical evidence generally favors tramadol over codeine alone. Codeine 60 mg by itself is a relatively weak analgesic, and its effectiveness is unpredictable because of genetic variation in metabolism. Tramadol shows a consistent dose-response curve and benefits from its additional non-opioid pain pathways.
That said, codeine combined with acetaminophen or aspirin performs substantially better than codeine alone. In clinical trials, aspirin 650 mg plus codeine 60 mg outperformed tramadol 100 mg for both dental and postsurgical pain. So the real-world comparison often isn’t codeine versus tramadol in isolation, but rather combination products versus tramadol, which narrows the gap considerably.
For people taking SSRIs or SNRIs, codeine may be the safer choice simply because it avoids the serotonin syndrome risk. For people with a history of seizures, codeine also has a modest safety advantage. Conversely, for someone whose CYP2D6 status is unknown and who isn’t on interacting medications, tramadol’s dual mechanism provides more reliable pain control.